Global NASH Market & Drug Pipeline Insights, 2020-2025, Featuring Intercept, Genfit, Allergan, Madrigal, Immuron, Galectin, and Gilead
Saturday, February 15, 2020
DUBLIN, Feb. 7, 2020 /PRNewswire/ -- The "NASH Drug Pipeline and Market Overview" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
No medications have been approved specifically for NASH but there are numerous products in development.
NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment of this disease in terms of developer, type of drug, phase study, and market entrance estimate.
In addition, the report provides the following data:
-- Estimated Treatment Cost for NASH Therapies, Low-, Mid-, High-Range,
30-day Supply
-- NASH Market Estimates by Global Region, 2025 Forecast (United States &
Canada, EMEA, Latin America, Asia Pacific)
In creating its market forecast, the analyst discusses the indicators that needed to be evaluated to create this estimate, commenting on:
-- NASH Disease Incidence and Prevalence
-- NAFLD Incidence and Prevalence
-- Risk Factor Evaluation
-- Pricing Trends
-- Liver Transplant Statistics and Trends
-- Expected Market Penetration
-- Global Treatment Options and Emerging Therapies
Key Topics Covered
Chapter 1: Executive Summary
-- Introduction
-- Market Summary
-- Competitive Summary
Chapter 2: NASH
-- Overview
Chapter 3: Products in Development
-- Introduction
-- Products in Development
-- Table 3-1: Products in Development for the Treatment of NASH 2019
Chapter 4: Market Opportunity
-- Overview
-- Figure 4-1: NASH Market Estimates by Global Region, 2025 Forecast
(United States & Canada, EMEA, Latin America, Asia Pacific)
-- Market Forecast Indicators
-- NASH Disease Incidence and Prevalence
-- NAFLD Incidence and Prevalence
-- Risk Factor Evaluation
-- Figure 4-2: Obesity and Diabetes Prevalence Rates (% of Population),
2016
-- Pricing Trends
-- Table 4-1: Estimated Treatment Cost for NASH Therapies, Low-, Mid-,
High-Range, 30-day supply
-- Liver Transplant Statistics and Trends
-- Figure 4-3: Liver Transplant Distribution by World Region, 2018
(Europe, Americas, Western Pacific, South-East Asia, Africa, Eastern
Mediterranean)
-- Expected Market Penetration
-- Global Treatment Options and Emerging Therapies
-- Competitive Overview
-- Intercept
-- Genfit
-- Allergan
-- Madrigal
-- Immuron
-- Galectin
-- Gilead
For more information about this report visit https://www.researchandmarkets.com/r/skr9zc
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-nash-market--drug-pipeline-insights-2020-2025-featuring-intercept-genfit-allergan-madrigal-immuron-galectin-and-gilead-301000895.html
SOURCE Research and Markets
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
|
|
Immutable Announces First Co-Founder-Hosted Live Webinar: How to Dominate Your Steam Launch | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
|
